GoodRx announced that QSYMIA® (phentermine and topiramate extended-release capsules CIV), a leading branded once-daily oral weight management medication, is now available for a low cash price exclusively through GoodRx. This offer is accessible at more than 70,000 retail pharmacy locations nationwide.
This initiative propels GoodRx’s momentum in providing solutions for weight loss, broadening its portfolio of significant savings on brand-name medications. The program aims to make obesity treatment more accessible and affordable for adults.
The exclusive pricing for QSYMIA® underscores GoodRx's commitment to addressing the high costs associated with weight management. It provides a direct pathway for consumers to access necessary treatments, regardless of their insurance status.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.